Search - tctmd.com

Displaying 181 - 200 of 273

Sort: Relevancy | Date

News Daily News

La PCI Radial + Bivalirudina es Eficaz Minimizando el Riesgo Hemorrágico

L.A. McKeown

August 19, 2013

Presentation

Comparison of Bivalirudin and Radial Access Across a Spectrum of Pre-PCI Bleeding Risk

Presenter: 222684|Dmitri Baklanov

August 09, 2013

News Daily News

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

Leah Lawrence

July 11, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Presentation

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Presenter: Jochen W?hrle

July 09, 2013

Presentation

Heparin vs. Bivalirudin in Patients with NSTE-ACS Undergoing PCI

Presenter: Oskar Anger?s

May 23, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Yael L. Maxwell

May 13, 2013

News Daily News

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

Yael L. Maxwell

May 13, 2013

News Daily News

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

L.A. McKeown

April 26, 2013

News Daily News

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

L.A. McKeown

April 26, 2013

Presentation

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Presenter: Siddharth A. Wayangankar

April 19, 2013

News Daily News

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Caitlin E. Cox

March 09, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

Presentation

Preprocedural Estimate of Individualized Bleeding Risk Impacts Physicians’ Bivalirudin Use During PCI

Presenter: S. C. Rao

March 05, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

February 27, 2013

Presentation TCT 2013

Impact of bivalirudin on peri-procedural events in patients undergoing rotational atherectomy: a subanalysis of the randomized ROTAXUS trial

Presenter: Mohamed Abdel-Wahab, Ahmed Khattab, Heinz Joachim B?ttner, Ralph Toelg, Volker Geist, Thomas Meinertz, Franz-Josef Neumann, Gert Richardt

January 31, 2013

Presentation TCT 2013

Heparin Versus Bivalirudin– In-hospital And 30 Day MACE In Patients Having DES Implantation

Presenter: Evan Shlofmitz, Richard Shlofmitz, Simcha Pollack, Elizabeth Cormier, Elizabeth Haag, Nathaniel Reichek

January 31, 2013

Presentation TCT 2013

Ecarin Clotting Time (ECT) more accurately reflects bivalirudin concentration than Activated Clotting Time (ACT) in patients undergoing Percutaneous Coronary Intervention using...

Presenter: Ronan Margey, Helen Ridgway, Richard Rullman, Jeff Spencer, Ronan Margey, Iris McNulty, Aditya Mangla, Sotir Polena, Daniel Soffer, Ik-Kyung Jang

January 31, 2013

Advertisement

La PCI Radial + Bivalirudina es Eficaz Minimizando el Riesgo Hemorrágico

Comparison of Bivalirudin and Radial Access Across a Spectrum of Pre-PCI Bleeding Risk

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Impact of Bivalirudin and Paclitaxel-Eluting Stents on Outcomes in Patients Undergoing Primary PCI of the LAD

Heparin vs. Bivalirudin in Patients with NSTE-ACS Undergoing PCI

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Prasugrel Noninferior to Ticagrelor in STEMI, but Both Require Hours to Achieve Effect

Prasugrel No es Inferior al Ticagrelor en los cuadros de STEMI, aunque Deben pasar Horas hasta que Ambos Hagan Efecto

La Bivalirudina Mejora a la Heprina en la Reducción del Riesgo Hemorrágico tras la CAS

Bivalirudin Bests Heparin for Lowering Bleeding Risk After CAS

Hemorrhagic and Ischemic Outcomes After Bivalirudin vs. Heparin During CAS

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Preprocedural Estimate of Individualized Bleeding Risk Impacts Physicians’ Bivalirudin Use During PCI

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

Impact of bivalirudin on peri-procedural events in patients undergoing rotational atherectomy: a subanalysis of the randomized ROTAXUS trial

Heparin Versus Bivalirudin– In-hospital And 30 Day MACE In Patients Having DES Implantation

Ecarin Clotting Time (ECT) more accurately reflects bivalirudin concentration than Activated Clotting Time (ACT) in patients undergoing Percutaneous Coronary Intervention using...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content